Full-stack compounded tissue repair as used in regenerative medicine settings. Higher doses, more compounds, and structured phasing than the biohacking version. Physician supervision required.
This protocol represents how tissue repair peptides are used in integrative medicine and regenerative clinics — primarily in the US, where compounding pharmacies operate under FDA guidance. The doses are higher, the compounds more tightly phased, and the blood work monitoring more rigorous than the community biohacking version of this stack.
It requires physician involvement not just for safety but for optimisation — the phasing of MGF, the timing of GHK-Cu introduction, and the loading/maintenance structure of TB-500 are best managed by a practitioner who can adjust based on imaging and functional assessments.
Months 1–2: BPC-157 and TB-500 loading phase — the most critical window for acute tissue repair. Month 3 onward: MGF added for muscle and tendon fibre reconstruction. Month 5 onward: GHK-Cu introduced to promote collagen remodelling and scar tissue quality as the healing process matures. Month 9–10: Taper and reassessment. The compound sequence is deliberate — adding everything simultaneously reduces the ability to attribute responses and increases the risk of over-stimulating repair pathways.
At month 8, imaging (MRI or ultrasound) if available provides the most objective assessment of healing progress. Functional tests — range of motion, strength testing, pain scores — at months 1, 4, and 8. Blood work: CRP and inflammatory markers quarterly. Liver panel at baseline and mid-point given the high BPC-157 dose.
Full dosing, titration schedule, blood work timing and cycling notes are available inside the platform. Use the calendar to track your protocol.